AzTrials
AzTrials

Plantar FasciitisNCT05258188

Comparison of Ergon Instruments-Assisted Soft Tissue Mobilization With Compressive Myofascial Release

A study testing Instrument-assisted Soft Tissue Mobilization and Compressive Myofascial Release Technique in people with Plantar Fasciitis, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to investigate the effects of Virtual Reality and Motor Imagery along with Routine Physical Therapy in motor function and balance in patients with Parkinson disease. Read more about this study

Who is it for?
Any age
Conditions the study is for
Plantar Fasciitis
What is being tested?
Instrument-assisted Soft Tissue Mobilization and Compressive Myofascial Release Technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
1 Mar 2021to 31 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Inability to achieve 20 degrees of active dorsiflexion,
  • Heel pain,
  • Mid foot pain,
  • Heal swelling,
  • Mid foot swelling,
  • Achilles' tendon tightness diagnosed on the base of Windlass test

Who cannot join

  • Recent foot injury,
  • Fracture,
  • Infections,
  • Surgical procedures,
  • Tendon injury,
  • Hypermobility,
Show all 14Show fewer
  • Neuromuscular disorders,
  • Impaired sensation,
  • Open sores,
  • Skin disease,
  • Active deep vein thrombosis or thrombophlebitis,
  • Bruises,
  • Varicose veins,
  • Burn scars

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Ripah International University

    Faisalabad, Punjab Province, 38000

Other trials in Pakistan

About this study

Official title: Study Comparing the Effectiveness of Ergon Instruments-Assisted Soft Tissue Mobilization Techniques With Compressive Myofascial Release for Plantar Fasciitis: A Randomised Clinical Trial

The objective of this study is to investigate the effects of Virtual Reality and Motor Imagery along with Routine Physical Therapy in motor function and balance in patients with Parkinson disease.

Read the detailed description

This randomized control trial is the single blinded, single centered study. Standard Protocol Items: Recommendations for Interventional Trials guidelines are used as study protocol. Sixty three patients of Parkinson Disease (Modified Hoehn and Yahr stages I-III) will randomly allocate into three groups.

Group A will be given a 60 min session of Virtual Reality along with Routine Physical Therapy.

Group B will be given a 60 min session of Motor Imagery along with Routine Physical Therapy.

Group C will be given a 40 min session of Routine Physical Therapy and after a short period of rest,20 min for walking and cycling.

These treatment sessions will be given to each group at every alternative day (3 days per week) for 12 weeks.

Outcome measures are

  1. Berg Balance Scale
  2. Activities Specific Balance Confidence Scale
  3. The Unified Parkinson Disease Rating Scale (part III) The Assessments will be recorded at baseline, at 6th and 12th weeks of therapy, and after one month of discontinuation of therapy.
Being tested
Instrument-assisted Soft Tissue Mobilization, Compressive Myofascial Release Technique
Keywords
Plantar Fascitis, Randomized Control Trial, Myofascial Release, Soft Tissue Mobilization, Ergon Instruments, Comparison
Medical subject headings
Fasciitis, Plantar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Instrument-assisted Soft Tissue MobilizationOther

    Instrument-assisted soft tissue mobilization is used for a mechanical benefit for the therapist providing deeper approach and braces remodeling of connective tissues through dissolution of extravagant fibrosis, while provoking repair and reconstructing forwarded by the recruitment of fibroblast.

  • Compressive Myofascial Release TechniqueOther

    Compressive Myofascial Release Technique is a technique of soft tissue stretching that uses compression and sustained myofascial stretches to create a releasing force in the targeted area

Study groups in NCT05258188
Study groupRoleWhat they receive
Instrument-assisted Soft Tissue MobilizationExperimental1. Warm-up will be performed for 10 to 15 minutes by light jogging, elliptical machine, stationary cycle or an upper body ergometer 2. Instrument-assisted Soft Tissue Mobilization , will be applied at 30 to 60 degrees angle for 40 to 120 seconds 3. Stretching, for 30 seconds (3 rep) 4. Strengthening exercises, high repetitions with low intensity exercise 5. Cryotherapy for 10 to 20 min
Receives: Other: Instrument-assisted Soft Tissue Mobilization
Compressive Myofascial Release TechniqueExperimentalCompressive myofascial release technique will be applied 5 minutes, after a warmup of 10 to 15 minutes.
Receives: Other: Compressive Myofascial Release Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Range of Motion

    Goniometer has been the most widely used tool for measuring joint range of motion. To ensure reliable measurement, standardized, specific positions and landmarks are used to measure each joint movement.

    Measured: 12th Week

  2. Visual Analogue Scale

    The Visual Analog Scale is a 10 cm line with anchor statements on the left, no pain and on the right, extreme pain.

    Measured: 12th Week

  3. Foot and Ankle Disability Index

    The Foot and Ankle Disability Index has 26 items. Each item is scored from 0; unable to do, to 4; no difficulty at all. The Foot and Ankle Disability Index has a total point value of 104 points.

    Measured: 12th Week

  4. Foot and Ankle Ability Measure

    The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument/questionaire developed to assess physical function for individuals with foot and ankle related impairments. 8-item Sports Subscale.

    Each item is scored on a 5-point Likert scale (4 to 0) from 'no difficulty at all' to 'unable to do'. Item score totals, which range from 0 to 84 for the ADL subscale and 0 to 32 for the Sports subscale, were transformed to percentage scores. Higher scores represent higher levels of function for each subscale, with 100% representing no dysfunction.

    Measured: 12th Week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2022
  2. Study start1 Mar 2021
  3. Primary completion25 Mar 2022
  4. Study completion31 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05258188
Sponsor's protocol ID
REC-FSD-00266
Status last verified
May 2022
First submitted
20 Feb 2022
Last updated
2 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Instrument-assisted Soft Tissue Mobilization and Compressive Myofascial Release Technique in people with Plantar Fasciitis, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Range of Motion (time frame: 12th Week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in